- Poster presentation
- Open Access
- Published:
Phage Display Selection of HIV Specific Conserved Mimotopes With IgG from Long-term Non-progressors
Retrovirology volume 2, Article number: P29 (2005)
Background
The aim of this study is to identify conserved epitopes of HIV-1 neutralizing antibodies in polyclonal plasma from LTNP to finally derive vaccine candidates.
Materials and methods
The presence of neutralizing antibodies in 9 LTNP sera was proved by in vitro neutralization assays. Phage displayed peptide libraries were screened with LTNP IgG. HIV-specific mimotopes were analyzed for homology to the gp120 structure by a software (3DEX) especially developed for this purpose. Mice were immunized with interesting phages and their sera were analyzed for neutralizing activities against HIV-1.
Results
After biopannings, between 19% and 75% HIV-specific phage clones were identified by ELISA. Mimotope sequences were identified and could be aligned by 3DEX to linear or conformational epitopes on gp120. A peptide specific immune response was detected in sera of immunized mice. The first mice sera analyzed showed neutralizing activities against HIV-1.
Conclusion
Mimotopes could be selected from LTNP sera that represent conformational epitopes on gp120. Those ones inducing neutralizing antibodies upon immunization potentially are suited to derive vaccine candidates.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Humber, M., Antoni, S., Schreiber, A. et al. Phage Display Selection of HIV Specific Conserved Mimotopes With IgG from Long-term Non-progressors. Retrovirology 2 (Suppl 1), P29 (2005). https://doi.org/10.1186/1742-4690-2-S1-P29
Published:
DOI: https://doi.org/10.1186/1742-4690-2-S1-P29
Keywords
- Peptide
- Immune Response
- Infectious Disease
- Cancer Research
- Neutralize Antibody